Cargando…
The clinical and molecular significance associated with STING signaling in breast cancer
STING signaling in cancer is a crucial component of response to immunotherapy and other anti-cancer treatments. Currently, there is no robust method of measuring STING activation in cancer. Here, we describe an immunohistochemistry-based assay with digital pathology assessment of STING in tumor cell...
Autores principales: | Parkes, Eileen E., Humphries, Matthew P., Gilmore, Elaine, Sidi, Fatima A., Bingham, Victoria, Phyu, Su M., Craig, Stephanie, Graham, Catherine, Miller, Joseph, Griffin, Daryl, Salto-Tellez, Manuel, Madden, Stephen F., Kennedy, Richard D., Bakhoum, Samuel F., McQuaid, Stephen, Buckley, Niamh E. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8233333/ https://www.ncbi.nlm.nih.gov/pubmed/34172750 http://dx.doi.org/10.1038/s41523-021-00283-z |
Ejemplares similares
-
Improving the Diagnostic Accuracy of the PD-L1 Test with Image Analysis and Multiplex Hybridization
por: Humphries, Matthew P., et al.
Publicado: (2020) -
PD-L1 Multiplex and Quantitative Image Analysis for Molecular Diagnostics
por: Abdullahi Sidi, Fatima, et al.
Publicado: (2020) -
Exploring the immune microenvironment in small bowel adenocarcinoma using digital image analysis
por: Sidi, Fatima Abdullahi, et al.
Publicado: (2023) -
Activation of STING-Dependent Innate Immune Signaling By S-Phase-Specific DNA Damage in Breast Cancer
por: Parkes, Eileen E., et al.
Publicado: (2016) -
Automated Tumour Recognition and Digital Pathology Scoring Unravels New Role for PD-L1 in Predicting Good Outcome in ER-/HER2+ Breast Cancer
por: Humphries, Matthew P., et al.
Publicado: (2018)